Proteasome inhibition in Hematologic Malignancies: Clinical Udate and Practical Applications. Oncology (Huntington). 2004;18(14 suppl 11):1-24. Copyright © 2004 CMP Healthcare.
Dalton WS. Proteasome inhibition in hematologic malignancies: clinical update and practical applications. Oncology (Huntington). 2004;18(14 suppl 11):3. Jung L, Holle L, Dalton WS. Discovery, development, and clinical application of bortezomib. Oncology (Huntington). 2004;18(14 suppl 11):4-13. Schwartz R, Davidson T. Pharmacology, pharmacokinetics, and practical applications of bortezomib. Oncology (Huntington). 2004;18(14 suppl 11): 14-21. Continuing Pharmacy Education Information 1) Learning Objectives 2) CE Course Evaluation Form 3) Continuing Pharmacy Education Post-Test
Dalton WS. Proteasome inhibition in hematologic malignancies: clinical update and practical applications. Oncology (Huntington). 2004;18(14 suppl 11):3.
Jung L, Holle L, Dalton WS. Discovery, development, and clinical application of bortezomib. Oncology (Huntington). 2004;18(14 suppl 11):4-13.
Schwartz R, Davidson T. Pharmacology, pharmacokinetics, and practical applications of bortezomib. Oncology (Huntington). 2004;18(14 suppl 11): 14-21.
Continuing Pharmacy Education Information 1) Learning Objectives 2) CE Course Evaluation Form 3) Continuing Pharmacy Education Post-Test
1) Learning Objectives 2) CE Course Evaluation Form 3) Continuing Pharmacy Education Post-Test